Vibrio parahaemolyticus bacteriophage Vib-PAP-4 and use thereof in inhibiting proliferation of Vibrio parahaemoliticus bacteria
AssigneeIntron Biotechnology, Inc.
InventorsSeong Jun Yoon, Soo Youn Jun, An Sung Kwon, Hyun Min Song, Soon Hye Hwang, Sang Hyeon Kang
Life of this patent
Estimating the term…
Abstract
The present invention relates to Myoviridae bacteriophage Vib-PAP-4(Accession No. KCTC 13168BP), isolated from nature, which possesses ability to specifically kill Vibrio parahaemolyticus bacteria and has the genome represented by SEQ ID No: 1, and a method for preventing infection of Vibrio parahaemolyticus bacteria and treating infection of Vibrio parahaemolyticus baceteria, using a composition containing the bacteriophage as an effective ingredient.
Claims1
A composition for blocking a Vibrio parahaemolyticus infection, inhibiting the development of diseases caused by a Vibrio parahaemolyticus infection, suppressing diseases caused by Vibrio parahaemolyticus, or alleviating the pathological condition of the diseases caused by Vibrio parahaemolyticus, comprising:
- maltodextrin and 1×104 pfu/g to 1×1015 plaque-forming units per gram (pfu/g) of proliferated and purified Myoviridae bacteriophage Vib-PAP-4, which has an ability to specifically kill Vibrio parahaemolyticus and a genome represented by SEQ ID NO:1, and is deposited in the Korean Collection for Type Cultures (KCTC) under accession number KCTC 13168BP,
- wherein the maltodextrin and Myoviridae bacteriophage Vib-PAP-4 are in a dried mixture.
Dependencies are inferred from the claim text.